{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:41:45Z","timestamp":1773326505609,"version":"3.50.1"},"reference-count":80,"publisher":"Pharmaceutical Society of Japan","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2013]]},"DOI":"10.1248\/bpb.b13-00319","type":"journal-article","created":{"date-parts":[[2013,7,31]],"date-time":"2013-07-31T23:36:46Z","timestamp":1375313806000},"page":"1241-1247","source":"Crossref","is-referenced-by-count":47,"title":["An Update on Peripheral Mechanisms and Treatments of Itch"],"prefix":"10.1248","volume":"36","author":[{"given":"Mitsutoshi","family":"Tominaga","sequence":"first","affiliation":[{"name":"Institute for Environmental and Gender Specific Medicine, Graduate School of Medicine, Juntendo University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Takamori","sequence":"additional","affiliation":[{"name":"Institute for Environmental and Gender Specific Medicine, Graduate School of Medicine, Juntendo University"},{"name":"Department of Dermatology, Juntendo University Urayasu Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Weisshaar E, Apfelbacher C, J\u00e4ger G, Zimmermann E, Bruckner T, Diepgen TL, Gollnick H. Pruritus as a leading symptom: clinical characteristics and quality of life in German and Ugandan patients. <i>Br. J. Dermatol.<\/i>, 155, 957\u2013964 (2006)."},{"key":"2","unstructured":"2) Pisoni RL, Wikstr\u00f6m B, Elder SJ, Akizawa T, Asano Y, Keen ML, Saran R, Mendelssohn DC, Young EW, Port FK. Pruritus in haemodialysis patients: International results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). <i>Nephrol. Dial. Transplant.<\/i>, 21, 3495\u20133505 (2006)."},{"key":"3","unstructured":"3) Picardi A, Lega I, Tarolla E. Suicide risk in skin disorders. <i>Clin. Dermatol.<\/i>, 31, 47\u201356 (2013)."},{"key":"4","unstructured":"4) Murota H, Kitaba S, Tani M, Wataya-Kaneda M, Azukizawa H, Tanemura A, Umegaki N, Terao M, Kotobuki Y, Katayama I. Impact of sedative and non-sedative antihistamines on the impaired productivity and quality of life in patients with pruritic skin diseases. <i>Allergol. Int.<\/i>, 59, 345\u2013354 (2010)."},{"key":"5","unstructured":"5) Ikoma A, Steinhoff M, St\u00e4nder S, Yosipovitch G, Schmelz M. The neurobiology of itch. <i>Nat. Rev. Neurosci.<\/i>, 7, 535\u2013547 (2006)."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Basbaum AI, Bautista DM, Scherrer G, Julius D. Cellular and molecular mechanisms of pain. <i>Cell<\/i>, 139, 267\u2013284 (2009).","DOI":"10.1016\/j.cell.2009.09.028"},{"key":"7","unstructured":"7) Tominaga M, Takamori K. Recent advances in pathophysiological mechanisms of itch. <i>Expert Rev. Dermatol.<\/i>, 5, 197\u2013212 (2010)."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Akiyama T, Tominaga M, Davoodi A, Nagamine M, Blansit K, Horwitz A, Carstens MI, Carstens E. Cross-sensitization of histamine-independent itch in mouse primary sensory neurons. <i>Neuroscience<\/i>, 226, 305\u2013312 (2012).","DOI":"10.1016\/j.neuroscience.2012.09.019"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Akiyama T, Carstens MI, Carstens E. Enhanced scratching evoked by PAR-2 agonist and 5-HT but not histamine in a mouse model of chronic dry skin itch. <i>Pain<\/i>, 151, 378\u2013383 (2010).","DOI":"10.1016\/j.pain.2010.07.024"},{"key":"10","unstructured":"10) Schuhknecht B, Marziniak M, Wissel A, Phan NQ, Pappai D, Dangelmaier J, Metze D, St\u00e4nder S. Reduced intraepidermal nerve fibre density in lesional and nonlesional prurigo nodularis skin as a potential sign of subclinical cutaneous neuropathy. <i>Br. J. Dermatol.<\/i>, 165, 85\u201391 (2011)."},{"key":"11","unstructured":"11) Taneda K, Tominaga M, Negi O, Tengara S, Kamo A, Ogawa H, Takamori K. Evaluation of epidermal nerve density and opioid receptor levels in psoriatic itch. <i>Br. J. Dermatol.<\/i>, 165, 277\u2013284 (2011)."},{"key":"12","unstructured":"12) Kou K, Nakamura F, Aihara M, Chen H, Seto K, Komori-Yamaguchi J, Kambara T, Nagashima Y, Goshima Y, Ikezawa Z. Decreased expression of semaphorin-3A, a neurite-collapsing factor, is associated with itch in psoriatic skin. <i>Acta Derm. Venereol.<\/i>, 92, 521\u2013528 (2012)."},{"key":"13","unstructured":"13) Tominaga M, Ozawa S, Ogawa H, Takamori K. A hypothetical mechanism of intraepidermal neurite formation in NC\/Nga mice with atopic dermatitis. <i>J. Dermatol. Sci.<\/i>, 46, 199\u2013210 (2007)."},{"key":"14","unstructured":"14) Tominaga M, Ogawa H, Takamori K. Histological characterization of cutaneous nerve fibers containing gastrin-releasing peptide in NC\/Nga mice: an atopic dermatitis model. <i>J. Invest. Dermatol.<\/i>, 129, 2901\u20132905 (2009)."},{"key":"15","unstructured":"15) Miyamoto T, Nojima H, Shinkado T, Nakahashi T, Kuraishi Y. Itch-associated response induced by experimental dry skin in mice. <i>Jpn. J. Pharmacol.<\/i>, 88, 285\u2013292 (2002)."},{"key":"16","unstructured":"16) Tominaga M, Ozawa S, Tengara S, Ogawa H, Takamori K. Intraepidermal nerve fibers increase in dry skin of acetone-treated mice. <i>J. Dermatol. Sci.<\/i>, 48, 103\u2013111 (2007)."},{"key":"17","unstructured":"17) Urashima R, Mihara M. Cutaneous nerves in atopic dermatitis. A histological, immunohistochemical and electron microscopic study. <i>Virchows Arch.<\/i>, 432, 363\u2013370 (1998)."},{"key":"18","unstructured":"18) Nakamura M, Toyoda M, Morohashi M. Pruritogenic mediators in psoriasis vulgaris: comparative evaluation of itch-associated cutaneous factors. <i>Br. J. Dermatol.<\/i>, 149, 718\u2013730 (2003)."},{"key":"19","unstructured":"19) Verge VM, Richardson PM, Wiesenfeld-Hallin Z, H\u00f6kfelt T. Differential influence of nerve growth factor on neuropeptide expression <i>in vivo<\/i>: a novel role in peptide suppression in adult sensory neurons. <i>J. Neurosci.<\/i>, 15, 2081\u20132096 (1995)."},{"key":"20","unstructured":"20) Steinhoff M, St\u00e4nder S, Seeliger S, Ansel JC, Schmelz M, Luger T. Modern aspects of cutaneous neurogenic inflammation. <i>Arch. Dermatol.<\/i>, 139, 1479\u20131488 (2003)."},{"key":"21","unstructured":"21) Roggenkamp D, Falkner S, St\u00e4b F, Petersen M, Schmelz M, Neufang G. Atopic keratinocytes induce increased neurite outgrowth in a coculture model of porcine dorsal root ganglia neurons and human skin cells. <i>J. Invest. Dermatol.<\/i>, 132, 1892\u20131900 (2012)."},{"key":"22","unstructured":"22) Rukwied RR, Main M, Weinkauf B, Schmelz M. NGF sensitizes nociceptors for cowhage- but not histamine-induced itch in human skin. <i>J. Invest. Dermatol.<\/i>, 133, 268\u2013270 (2013)."},{"key":"23","unstructured":"23) Takaoka K, Shirai Y, Saito N. Inflammatory cytokine tumor necrosis factor-alpha enhances nerve growth factor production in human keratinocytes, HaCaT cells. <i>J. Pharmacol. Sci.<\/i>, 111, 381\u2013391 (2009)."},{"key":"24","unstructured":"24) Wood LC, Jackson SM, Elias PM, Grunfeld C, Feingold KR. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. <i>J. Clin. Invest.<\/i>, 90, 482\u2013487 (1992)."},{"key":"25","unstructured":"25) Kimura H, Schubert D. Schwannoma-derived growth factor promotes the neuronal differentiation and survival of PC12 cells. <i>J. Cell Biol.<\/i>, 116, 777\u2013783 (1992)."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Nilsson A, Kanje M. Amphiregulin acts as an autocrine survival factor for adult sensory neurons. <i>Neuroreport<\/i>, 16, 213\u2013218 (2005).","DOI":"10.1097\/00001756-200502280-00002"},{"key":"27","unstructured":"27) Chung E, Cook PW, Parkos CA, Park YK, Pittelkow MR, Coffey RJ. Amphiregulin causes functional downregulation of adherens junctions in psoriasis. <i>J. Invest. Dermatol.<\/i>, 124, 1134\u20131140 (2005)."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Murota H, Izumi M, Abd El-Latif MI, Nishioka M, Terao M, Tani M, Matsui S, Sano S, Katayama I. Artemin causes hypersensitivity to warm sensation, mimicking warmth-provoked pruritus in atopic dermatitis. <i>J. Allergy Clin. Immunol.<\/i>, 130, 671\u2013682, e4 (2012).","DOI":"10.1016\/j.jaci.2012.05.027"},{"key":"29","unstructured":"29) Paus R, Schmelz M, B\u00edr\u00f3 T, Steinhoff M. Frontiers in pruritus research: scratching the brain for more effective itch therapy. <i>J. Clin. Invest.<\/i>, 116, 1174\u20131186 (2006)."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Fujisawa H. Discovery of semaphorin receptors, neuropilin and plexin, and their functions in neural development. <i>J. Neurobiol.<\/i>, 59, 24\u201333 (2004).","DOI":"10.1002\/neu.10337"},{"key":"31","unstructured":"31) Tang XQ, Tanelian DL, Smith GM. Semaphorin 3A inhibits nerve growth factor-induced sprouting of nociceptive afferents in adult rat spinal cord. <i>J. Neurosci.<\/i>, 24, 819\u2013827 (2004)."},{"key":"32","unstructured":"32) Dontchev VD, Letourneau PC. Nerve growth factor and semaphorin 3A signaling pathways interact in regulating sensory neuronal growth cone motility. <i>J. Neurosci.<\/i>, 22, 6659\u20136669 (2002)."},{"key":"33","unstructured":"33) Tominaga M, Ogawa H, Takamori K. Decreased production of semaphorin 3A in the lesional skin of atopic dermatitis. <i>Br. J. Dermatol.<\/i>, 158, 842\u2013844 (2008)."},{"key":"34","unstructured":"34) Fukamachi S, Bito T, Shiraishi N, Kobayashi M, Kabashima K, Nakamura M, Tokura Y. Modulation of semaphorin 3A expression by calcium concentration and histamine in human keratinocytes and fibroblasts. <i>J. Dermatol. Sci.<\/i>, 61, 118\u2013123 (2011)."},{"key":"35","unstructured":"35) Kamo A, Tominaga M, Negi O, Tengara S, Ogawa H, Takamori K. Topical application of emollients prevents dry skin-inducible intraepidermal nerve growth in acetone-treated mice. <i>J. Dermatol. Sci.<\/i>, 62, 64\u201366 (2011)."},{"key":"36","unstructured":"36) Kamo A, Tominaga M, Tengara S, Ogawa H, Takamori K. Inhibitory effects of UV-based therapy on dry skin-inducible nerve growth in acetone-treated mice. <i>J. Dermatol. Sci.<\/i>, 62, 91\u201397 (2011)."},{"key":"37","unstructured":"37) Soussi-Yanicostas N, Hardelin JP, Arroyo-Jimenez MM, Ardouin O, Legouis R, Levilliers J, Traincard F, Betton JM, Cabani\u00e9 L, Petit C. Initial characterization of anosmin-1, a putative extracellular matrix protein synthesized by definite neuronal cell populations in the central nervous system. <i>J. Cell Sci.<\/i>, 109, 1749\u20131757 (1996)."},{"key":"38","unstructured":"38) Tengara S, Tominaga M, Kamo A, Taneda K, Negi O, Ogawa H, Takamori K. Keratinocyte-derived anosmin-1, an extracellular glycoprotein encoded by the X-linked Kallmann syndrome gene, is involved in modulation of epidermal nerve density in atopic dermatitis. <i>J. Dermatol. Sci.<\/i>, 58, 64\u201371 (2010)."},{"key":"39","unstructured":"39) Tominaga M, Kamo A, Tengara S, Ogawa H, Takamori K. <i>In vitro<\/i> model for penetration of sensory nerve fibres on a Matrigel basement membrane: implications for possible application to intractable pruritus. <i>Br. J. Dermatol.<\/i>, 161, 1028\u20131037 (2009)."},{"key":"40","unstructured":"40) Tominaga M, Tengara S, Kamo A, Ogawa H, Takamori K. Matrix metalloproteinase-8 is involved in dermal nerve growth: implications for possible application to pruritus from <i>in vitro<\/i> models. <i>J. Invest. Dermatol.<\/i>, 131, 2105\u20132112 (2011)."},{"key":"41","unstructured":"41) Grabham PW, Goldberg DJ. Nerve growth factor stimulates the accumulation of beta1 integrin at the tips of filopodia in the growth cones of sympathetic neurons. <i>J. Neurosci.<\/i>, 17, 5455\u20135465 (1997)."},{"key":"42","unstructured":"42) Gardiner NJ. Integrins and the extracellular matrix: key mediators of development and regeneration of the sensory nervous system. <i>Dev. Neurobiol.<\/i>, 71, 1054\u20131072 (2011)."},{"key":"43","unstructured":"43) Zhou Y, Gunput RA, Pasterkamp RJ. Semaphorin signaling: progress made and promises ahead. <i>Trends Biochem. Sci.<\/i>, 33, 161\u2013170 (2008)."},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Sun YG, Chen ZF. A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord. <i>Nature<\/i>, 448, 700\u2013703 (2007).","DOI":"10.1038\/nature06029"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Andoh T, Kuwazono T, Lee JB, Kuraishi Y. Gastrin-releasing peptide induces itch-related responses through mast cell degranulation in mice. <i>Peptides<\/i>, 32, 2098\u20132103 (2011).","DOI":"10.1016\/j.peptides.2011.09.003"},{"key":"46","unstructured":"46) Kagami S, Sugaya M, Suga H, Morimura S, Kai H, Ohmatsu H, Fujita H, Tsunemi Y, Sato S. Serum gastrin-releasing peptide levels correlate with pruritus in patients with atopic dermatitis. <i>J. Invest. Dermatol.<\/i>, 133, 1673\u20131675 (2013)."},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Dong X, Han S, Zylka MJ, Simon MI, Anderson DJ. A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons. <i>Cell<\/i>, 106, 619\u2013632 (2001).","DOI":"10.1016\/S0092-8674(01)00483-4"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Liu Q, Tang Z, Surdenikova L, Kim S, Patel KN, Kim A, Ru F, Guan Y, Weng HJ, Geng Y, Undem BJ, Kollarik M, Chen ZF, Anderson DJ, Dong X. Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-induced pruritus. <i>Cell<\/i>, 139, 1353\u20131365 (2009).","DOI":"10.1016\/j.cell.2009.11.034"},{"key":"49","unstructured":"49) Abila B, Ezeamuzie IC, Igbigbi PS, Ambakederemo AW, Asomugha L. Effects of two antihistamines on chloroquine and histamine induced weal and flare in healthy African volunteers. <i>Afr. J. Med. Med. Sci.<\/i>, 23, 139\u2013142 (1994)."},{"key":"50","unstructured":"50) Sikand P, Dong X, LaMotte RH. BAM8-22 peptide produces itch and nociceptive sensations in humans independent of histamine release. <i>J. Neurosci.<\/i>, 31, 7563\u20137567 (2011)."},{"key":"51","unstructured":"51) Han L, Ma C, Liu Q, Weng HJ, Cui Y, Tang Z, Kim Y, Nie H, Qu L, Patel KN, Li Z, McNeil B, He S, Guan Y, Xiao B, Lamotte RH, Dong X. A subpopulation of nociceptors specifically linked to itch. <i>Nat. Neurosci.<\/i>, 16, 174\u2013182 (2013)."},{"key":"52","unstructured":"52) Takano N, Sakurai T, Kurachi M. Effects of anti-nerve growth factor antibody on symptoms in the NC\/Nga mouse, an atopic dermatitis model. <i>J. Pharmacol. Sci.<\/i>, 99, 277\u2013286 (2005)."},{"key":"53","unstructured":"53) Takano N, Sakurai T, Ohashi Y, Kurachi M. Effects of high-affinity nerve growth factor receptor inhibitors on symptoms in the NC\/Nga mouse atopic dermatitis model. <i>Br. J. Dermatol.<\/i>, 156, 241\u2013246 (2007)."},{"key":"54","unstructured":"54) Yamaguchi J, Nakamura F, Aihara M, Yamashita N, Usui H, Hida T, Takei K, Nagashima Y, Ikezawa Z, Goshima Y. Semaphorin 3A alleviates skin lesions and scratching behavior in NC\/Nga mice, an atopic dermatitis model. <i>J. Invest. Dermatol.<\/i>, 128, 2842\u20132849 (2008)."},{"key":"55","unstructured":"55) Negi O, Tominaga M, Tengara S, Kamo A, Taneda K, Suga Y, Ogawa H, Takamori K. Topically applied semaphorin 3A ointment inhibits scratching behavior and improves skin inflammation in NC\/Nga mice with atopic dermatitis. <i>J. Dermatol. Sci.<\/i>, 66, 37\u201343 (2012)."},{"key":"56","unstructured":"56) Romeo PH, Lemarchandel V, Tordjman R. Neuropilin-1 in the immune system. <i>Adv. Exp. Med. Biol.<\/i>, 515, 49\u201354 (2002)."},{"key":"57","unstructured":"57) Murota H, El-latif MA, Tamura T, Amano T, Katayama I. Olopatadine hydrochloride improves dermatitis score and inhibits scratch behavior in NC\/Nga mice. <i>Int. Arch. Allergy Immunol.<\/i>, 153, 121\u2013132 (2010)."},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Ohsawa Y, Hirasawa N. The antagonism of histamine H1 and H4 receptors ameliorates chronic allergic dermatitis <i>via<\/i> anti-pruritic and anti-inflammatory effects in NC\/Nga mice. <i>Allergy<\/i>, 67, 1014\u20131022 (2012).","DOI":"10.1111\/j.1398-9995.2012.02854.x"},{"key":"59","unstructured":"59) Yoshii H, Suehiro S, Watanabe K, Yanagihara Y. Immunopharmacological actions of an extract isolated from inflamed skin of rabbits inoculated with vaccinia virus (neurotropin); enhancing effect on delayed type hypersensitivity response through the induction of Lyt-1+2-T cells. <i>Int. J. Immunopharmacol.<\/i>, 9, 443\u2013451 (1987)."},{"key":"60","unstructured":"60) Clinical Research Group for Neurotropin. Double blind study on antiprurigous effect of neurotropin on chronic uriticaria and eczematous dermatitis. <i>Nishinihon J. Dermatol.<\/i>, 41, 552\u2013559 (1979)."},{"key":"61","unstructured":"61) Yago H, Fujita Y, Kaku H, Naka F, Nishikawa K, Kawakubo H, Nakano K, Matsumoto K, Suehiro S. Study on pruritus in hemodialysis patients and the antipruritic effect of neurotropin: plasma levels of C3a, C5a, bradykinin and lipid peroxides. <i>Nippon Jinzo Gakkai Shi<\/i>, 31, 1061\u20131067 (1989)."},{"key":"62","unstructured":"62) Taneda K, Tominaga M, Tengara S, Ogawa H, Takamori K. Neurotropin inhibits both capsaicin-induced substance P release and nerve growth factor-induced neurite outgrowth in cultured rat dorsal root ganglion neurones. <i>Clin. Exp. Dermatol.<\/i>, 35, 73\u201377 (2010)."},{"key":"63","doi-asserted-by":"crossref","unstructured":"63) Kamo A, Tominaga M, Taneda K, Ogawa H, Takamori K. Neurotropin inhibits the increase in intraepidermal nerve density in the acetone-treated dry-skin mouse model. doi: (2013).","DOI":"10.1111\/ced.12100"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64) Krutmann J. Phototherapy for atopic dermatitis. <i>Clin. Exp. Dermatol.<\/i>, 25, 552\u2013558 (2000).","DOI":"10.1046\/j.1365-2230.2000.00700.x"},{"key":"65","unstructured":"65) Wallengren J, Sundler F. Phototherapy reduces the number of epidermal and CGRP-positive dermal nerve fibres. <i>Acta Derm. Venereol.<\/i>, 84, 111\u2013115 (2004)."},{"key":"66","unstructured":"66) Tominaga M, Tengara S, Kamo A, Ogawa H, Takamori K. Psoralen-ultraviolet A therapy alters epidermal Sema3A and NGF levels and modulates epidermal innervation in atopic dermatitis. <i>J. Dermatol. Sci.<\/i>, 55, 40\u201346 (2009)."},{"key":"67","unstructured":"67) Phan NQ, Lotts T, Antal A, Bernhard JD, St\u00e4nder S. Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review. <i>Acta Derm. Venereol.<\/i>, 92, 555\u2013560 (2012)."},{"key":"68","unstructured":"68) Kumagai H, Ebata T, Takamori K, Miyasato K, Muramatsu T, Nakamoto H, Kurihara M, Yanagita T, Suzuki H. Efficacy and safety of a novel \u03ba-agonist for managing intractable pruritus in dialysis patients. <i>Am. J. Nephrol.<\/i>, 36, 175\u2013183 (2012)."},{"key":"69","unstructured":"69) Inan S, Cowan A. Kappa opioid agonists suppress chloroquine-induced scratching in mice. <i>Eur. J. Pharmacol.<\/i>, 502, 233\u2013237 (2004)."},{"key":"70","unstructured":"70) Bigliardi PL, Stammer H, Jost G, Rufli T, B\u00fcchner S, Bigliardi-Qi M. Treatment of pruritus with topically applied opiate receptor antagonist. <i>J. Am. Acad. Dermatol.<\/i>, 56, 979\u2013988 (2007)."},{"key":"71","unstructured":"71) Tominaga M, Ogawa H, Takamori K. Possible roles of epidermal opioid systems in pruritus of atopic dermatitis. <i>J. Invest. Dermatol.<\/i>, 127, 2228\u20132235 (2007)."},{"key":"72","doi-asserted-by":"crossref","unstructured":"72) Wallengren J. Neuroanatomy and neurophysiology of itch. <i>Dermatol. Ther.<\/i>, 18, 292\u2013303 (2005).","DOI":"10.1111\/j.1529-8019.2005.00041.x"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73) Carstens EE, Carstens MI, Simons CT, Jinks SL. Dorsal horn neurons expressing NK-1 receptors mediate scratching in rats. <i>Neuroreport<\/i>, 21, 303\u2013308 (2010).","DOI":"10.1097\/WNR.0b013e328337310a"},{"key":"74","unstructured":"74) Akiyama T, Tominaga M, Davoodi A, Nagamine M, Blansit K, Horwitz A, Carstens MI, Carstens E. Roles for substance P and gastrin-releasing peptide as neurotransmitters released by primary afferent pruriceptors. <i>J. Neurophysiol.<\/i>, 109, 742\u2013748 (2013)."},{"key":"75","doi-asserted-by":"crossref","unstructured":"75) Quartara L, Altamura M. Tachykinin receptors antagonists: from research to clinic. <i>Curr. Drug Targets<\/i>, 7, 975\u2013992 (2006).","DOI":"10.2174\/138945006778019381"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76) Hesketh PJ. Chemotherapy-induced nausea and vomiting. <i>N. Engl. J. Med.<\/i>, 358, 2482\u20132494 (2008).","DOI":"10.1056\/NEJMra0706547"},{"key":"77","unstructured":"77) Duval A, Dubertret L. Aprepitant as an antipruritic agent? <i>N. Engl. J. Med.<\/i>, 361, 1415\u20131416 (2009)."},{"key":"78","unstructured":"78) St\u00e4nder S, Siepmann D, Herrgott I, Sunderk\u00f6tter C, Luger TA. Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy. <i>PLoS ONE<\/i>, 5, e10968 (2010)."},{"key":"79","unstructured":"79) Thurmond RL, Gelfand EW, Dunford PJ. The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines. <i>Nat. Rev. Drug Discov.<\/i>, 7, 41\u201353 (2008)."},{"key":"80","unstructured":"80) Dunford PJ, Williams KN, Desai PJ, Karlsson L, McQueen D, Thurmond RL. Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus. <i>J. Allergy Clin. Immunol.<\/i>, 119, 176\u2013183 (2007)."}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/36\/8\/36_b13-00319\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T05:22:09Z","timestamp":1615872129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/36\/8\/36_b13-00319\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":80,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b13-00319","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}